Morgan Ebert, Managing Editor

Epigenetic aging raises colorectal cancer risk in postmenopausal women, but higher fruit and vegetable intake may help offset this risk.

OTC oral contraceptives boost access, with more women starting effective birth control, especially uninsured and rural populations.

Hypertensive disorders in pregnancy affect fetal growth differently by sex, with males prioritizing growth and females adapting via placental development.

Counties with persistently low cervical cancer screening rates have nearly double the rates of late-stage diagnoses and mortality, study finds.

AI model predicts delivery timing from ultrasound images with high accuracy, offering a potential tool for preterm birth risk assessment.

Study finds women 65+ experience sexual dysfunction at rates similar to midlife women but report less distress over sexual health concerns.

Higher maternal vitamin D in early pregnancy linked to better fluid and overall cognition in children, especially among those of Black mothers.

FDA accepts priority review of gepotidacin, a first-in-class oral antibiotic, for treating uncomplicated urogenital gonorrhea in patients 12 years and older.

Increasing daily sit-to-stand transitions lowered diastolic blood pressure in postmenopausal women, offering a simple strategy to support heart health.

A recent survey reveals significant gaps in public knowledge about pregnancy health, including misconceptions on weight gain, supplements, and vaccine safety.

Preconception hypoglycemia is linked to increased risks of preterm birth, low birth weight, and birth defects, a new study from China finds.

Take a quick look at everything you may have missed last month, including the latest FDA updates, top stories, and exclusive interviews.

SARS-CoV-2 infection during pregnancy alters placental gene expression and increases pathology, especially when contracted in the first trimester.

A new ACOG clinical guidance offers updated recommendations on umbilical cord management for preterm births based on recent evidence and analysis.

"The FDA did not raise any concern regarding the general approvability of elinzanetant in its correspondence," according to an anouncement from Bayer.

Kephera Diagnostics announced the launch of EndomTest, a noninvasive blood test for endometriosis, promising faster diagnoses and improved patient care.

Study finds USPSTF guidelines label 89% of pregnancies as at risk for preeclampsia, but moderate risk factors offer limited value in guiding aspirin use.

Experts debate the risks and benefits of SSRIs during pregnancy, emphasizing the need for better education and transparency in treatment options.

Experts urge the FDA to update outdated warnings on menopausal hormone therapies, emphasizing the safety and benefits of low-dose vaginal estrogen.

Nearly one-third of women with premature ovarian insufficiency experience depressive symptoms, according to a recent study.

Research reveals significant treatment gaps for hepatitis C in postpartum women and children, highlighting urgent needs for improved care access and awareness.

Women with endometriosis-related infertility are more likely to conceive than those with other causes of infertility, a 30-year study shows.

A pro-inflammatory maternal diet during pregnancy was linked to a 16% higher risk of type 1 diabetes in offspring, Danish cohort study finds.

A roundup of the most impactful FDA approvals in women’s health from January through June 2025, spanning diagnostics, therapeutics, and at-home care.

A look back at the most important FDA approvals, clinical research, and expert perspectives shaping ob-gyn care in the first half of 2025.

Take a quick look at everything you may have missed during Q2 of 2025, including the latest FDA approvals, top stories, and exclusive interviews.

Take a quick look at everything you may have missed last month, including the latest FDA updates and top stories.

Oral sulopenem (ORLYNVAH; Iterum Therapeutics) was non-inferior to amoxicillin/clavulanate for treating uUTIs in women, per the phase 3 REASSURE trial.

Wildfire smoke and heat stress before and early in pregnancy raise the risk of SGA births, especially in climate-vulnerable neighborhoods.

Higher third-trimester glucose levels in insulin-dependent pregnancies are tied to increased obesity risk in adult offspring, a 40-year study finds.